Inclusion and exclusion criteria for phase II trial. The inclusion and exclusion criteria are displayed, per trial protocol. Notably, the inclusion criteria feature an initial hemoglobin level ≥10 g/dL. Patients who have had metastatic disease, received systemic anticancer therapy at any time, or had surgery/radiotherapy in the past 4 weeks were excluded.